Dry air, which is quite common in certain geographic locations in the winter, can severely affect skin health. Dr. Howard ...

The pick is also great for sensitive skin—and it’s on sale for under $20.

Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...

That uncomfortable urge to scratch your palms might be more than just an annoyance. While some dismiss itchy palms as merely ...

According to Future Market Insights, Inc., the global omega-3 pet supplement market value is estimated to total USD 1,280.7 ...

Study highlights barriers to care, treatment preferences, and interest in research participation in psoriasis in the Latine ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis ...

The following is a summary of “FC02 Immune cell signatures and T-cell receptor profiling reveal pathogenetic mechanisms in psoriasis,” published in the December 2024 issue of Dermatology by Deng et al ...

A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors.